Syphilis Testing Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $3,650.3 million by 2020, registering a CAGR of 1.2% during the period 2014-2020. The secondary syphilis testing would continue to be the largest market segment through 2020.Latin America,Middle East&Africa(LAMEA) market accounted for about 43% revenue share of the syphilis testing market in 2014.
Rising Syphilis cases remain a vital public health issue and is a significant concern across the globe, especially in developing economies. Rising burden of syphilis incidences and implementation of national screening programs are major factors fuelling the growth of Syphilis testing worldwide. Furthermore, the growing adoption of novel technologies such as Enzyme Immunoassay (EIA) tests, Darkfield microscopy and Microhemagglutination (MHA-TP) assay enables faster and improved screening results – thus provides additional boost to the market growth. However, social stigma associated with patients visiting to STD clinics and large patient pool in remote areas would limit the market growth to a certain extent.
To Remain ‘Ahead’ Of Your Competitors, Request For A Sample at: https://www.alliedmarketresearch.com/request-sample/675
COVID-19 scenario analysis:
1) The COVID-19 impact on the Syphilis testing market is unpredictable and is expected to remain in force till the fourth quarter of 2021.
2) The COVID-19 outbreak forced governments across the globe to implement strict lockdowns and banned import-export of nonessential items for most of 2021. This led to sudden fall in the availability of important raw materials.
3) Moreover, nationwide lockdowns forced manufacturing facilities to partially or completely shut their operations.
4) Adverse impacts of the COVID-19 pandemic have resulted in delays in activities and initiatives regarding development of reliable and innovative drone analytics systems globally.
Inquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/request-for-customization/675?reqfor=covid
Key Findings of the Syphilis Testing Market:
LAMEA will continue to lead the global market, closely followed by Asia Pacific, all through the analysis period
United states remains a major market in the North Americasyphilis testing market through 2020
Spainand Germanycollectively accounts for about one fourth of the Europesyphilis testing market
ChinaandIndiacollectively accounts for about 89% share in theAsia Pacificsyphilis testing market
List of Key Players Profiled in the Report:
Roche Diagnostics, Hologic, Inc., Becton Dickinson & Company, Abbott Laboratories, BioMerieux, Alere Inc., Cepheid Inc., Affymetrix, Inc. and Diasorin.
To Get Discount, Make Purchase Inquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/675
Trending Reports In Healthcare Industry:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.